T 0841/23 (Avelumab flat dosing/PFIZER INC.) of 07.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T084123.20250107
- Date of decision
- 7 January 2025
- Case number
- T 0841/23
- Online on
- 1 April 2025
- Petition for review of
- -
- Application number
- 17784701.9
- IPC class
- A61P 35/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Dosing regimen of avelumab for the treatment of cancer
- Applicant name
- Pfizer Inc.
Merck Patent GmbH - Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendment to appeal case - suitability of amendment to resolve issues raised (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
- The appeal is dismissed